Logos Global Management’s Aptose Biosciences APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
OM
Logos Global Management's APTO Position: Q3 2020 in Review
Logos Global Management sold out of Aptose Biosciences (APTO) in Q3 2020, closing a stake of 1,667 shares — an estimated $4.73M sold.
Logos Global Management first reported a position in APTO in Q4 2019 and held it in 2 quarters. The position peaked at $4.73M in Q2 2020. 64 funds tracked by Wall St. Rank hold APTO as of Q3 2020.
- Logos Global Management reported no remaining Aptose Biosciences position as of Q3 2020 after selling out during the quarter.
- Logos Global Management sold 1,667 Aptose Biosciences shares in Q3 2020, an estimated $4.73M.
- Logos Global Management first reported a position in Aptose Biosciences in Q4 2019 and held it in 2 quarters.
- Logos Global Management's Aptose Biosciences position peaked at $4.73M in Q2 2020.
- 64 funds tracked by Wall St. Rank held Aptose Biosciences as of Q3 2020.
Based on Logos Global Management's 13F filing for Q3 2020, filed 16 Nov 2020.